National Bank of Canada
EW icon

National Bank of Canada’s Edwards Lifesciences EW Stock Holding History

National Bank of Canada’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4M Buy
357,656
+54,407
+18% +$4.56M 0.02% 430
2026
Q1 		$24.3M Sell
303,249
-19,710
-6% -$1.62M 0.02% 443
2025
Q4 		$27.5M Sell
322,959
-47,455
-13% -$3.89M 0.03% 443
2025
Q3 		$28.8M Sell
370,414
-88,239
-19% -$6.89M 0.03% 403
2025
Q2 		$35.9M Sell
458,653
-82,878
-15% -$6.18M 0.03% 374
2025
Q1 		$39.2M Buy
541,531
+209,144
+63% +$15M 0.04% 357
2024
Q4 		$24.6M Buy
332,387
+28,534
+9% +$2M 0.03% 503
2024
Q3 		$20.1M Buy
303,853
+65,982
+28% +$4.79M 0.02% 482
2024
Q2 		$21.5M Buy
237,871
+34,635
+17% +$3.07M 0.03% 373
2024
Q1 		$17.6M Sell
203,236
-11,625
-5% -$977K 0.03% 453
2023
Q4 		$16.2M Buy
214,861
+9,352
+5% +$651K 0.03% 457
2023
Q3 		$14.2M Buy
205,509
+33,350
+19% +$2.68M 0.02% 505
2023
Q2 		$15.8M Buy
172,159
+77,698
+82% +$6.75M 0.03% 422
2023
Q1 		$7.79M Buy
94,461
+53,633
+131% +$4.22M 0.02% 483
2022
Q4 		$3.05M Sell
40,828
-12,565
-24% -$968K 0.01% 766
2022
Q3 		$4.41M Buy
53,393
+34,177
+178% +$3.29M 0.02% 561
2022
Q2 		$1.83M Sell
19,216
-2,585
-12% -$268K 0.01% 810
2022
Q1 		$2.57M Sell
21,801
-8,439
-28% -$947K 0.01% 804
2021
Q4 		$3.9M Buy
+30,240
New +$3.53M 0.01% 625

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

National Bank of Canada's EW Position: Q2 2026 in Review

National Bank of Canada increased its Edwards Lifesciences (EW) stake by 18% in Q2 2026, buying an estimated $4.56M and bringing the position to 357,656 shares worth $32.4M. The position accounts for 0.02% of the portfolio, ranked #430.

National Bank of Canada first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $39.2M in Q1 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • National Bank of Canada held 357,656 shares of Edwards Lifesciences worth $32.4M as of Q2 2026.
  • National Bank of Canada bought 54,407 Edwards Lifesciences shares in Q2 2026, an estimated $4.56M.
  • Edwards Lifesciences made up 0.02% of National Bank of Canada's portfolio in Q2 2026, its #430 holding.
  • National Bank of Canada first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Edwards Lifesciences position peaked at $39.2M in Q1 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.